Furthermore, activated BRAF promotes cell survival by inducing the expression or the phosphorylation of BCL-2 family members [24, 25] and suppresses apoptotic responses against staurosporine and TNFα/cycloheximide in thyroid carcinoma cells [7]. Here, BCL2 is linked to thyroid gland carcinoma.